Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Paterson

Showing results (71-80 of 574) with videos related to

Pageof 58
Sort By:
The New England Journal of Medicine|May 29, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract InfectionAbi Manesh, George M Varghese, David L Paterson
Annals of Internal Medicine|November 19, 2003
Linezolid: the first oxazolidinone antimicrobialDavid L Paterson, A William Pasculle, Kenneth McCurry
Clinical Microbiology Reviews|July 16, 2008
Acinetobacter baumannii: emergence of a successful pathogenAnton Y Peleg, Harald Seifert, David L Paterson
JAMA Internal Medicine|February 14, 2022
For and Against Routine Removal of Peripheral Intravenous CathetersClaire M Rickard, David L Paterson, Vineet Chopra
Microbial Drug Resistance (Larchmont, N.Y.)|February 26, 2015
Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and OceaniaWitchuda Kamolvit, Hanna E Sidjabat, David L Paterson
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
An Australian perspective on antimicrobial stewardship programs and transplantationAdam G Stewart, Burcu Isler, David L Paterson
Antimicrobial Agents and Chemotherapy|March 26, 2008
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidansYohei Doi, Laurent Poirel, David L Paterson, et al.
Current Opinion in Infectious Diseases|December 14, 2019
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremiaDavid L Paterson, Andrew Henderson, Patrick N A Harris
The Canadian Journal of Urology|September 6, 2007
Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxisGlenn M Cannon, Marc C Smaldone, David L Paterson
Infectious Disease Clinics of North America|December 13, 2025
Current Management Strategies for Stenotrophomonas maltophiliaYa-Ting Chang, Po-Liang Lu, David L Paterson
Pageof 58

Showing results (71-80 of 574) with videos related to

Sort By:
Pageof 58
The New England Journal of Medicine|May 29, 2024
Cefepime-Taniborbactam in Complicated Urinary Tract InfectionAbi Manesh, George M Varghese, David L Paterson
Annals of Internal Medicine|November 19, 2003
Linezolid: the first oxazolidinone antimicrobialDavid L Paterson, A William Pasculle, Kenneth McCurry
Clinical Microbiology Reviews|July 16, 2008
Acinetobacter baumannii: emergence of a successful pathogenAnton Y Peleg, Harald Seifert, David L Paterson
JAMA Internal Medicine|February 14, 2022
For and Against Routine Removal of Peripheral Intravenous CathetersClaire M Rickard, David L Paterson, Vineet Chopra
Microbial Drug Resistance (Larchmont, N.Y.)|February 26, 2015
Molecular Epidemiology and Mechanisms of Carbapenem Resistance of Acinetobacter spp. in Asia and OceaniaWitchuda Kamolvit, Hanna E Sidjabat, David L Paterson
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 18, 2022
An Australian perspective on antimicrobial stewardship programs and transplantationAdam G Stewart, Burcu Isler, David L Paterson
Antimicrobial Agents and Chemotherapy|March 26, 2008
Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidansYohei Doi, Laurent Poirel, David L Paterson, et al.
Current Opinion in Infectious Diseases|December 14, 2019
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremiaDavid L Paterson, Andrew Henderson, Patrick N A Harris
The Canadian Journal of Urology|September 6, 2007
Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxisGlenn M Cannon, Marc C Smaldone, David L Paterson
Infectious Disease Clinics of North America|December 13, 2025
Current Management Strategies for Stenotrophomonas maltophiliaYa-Ting Chang, Po-Liang Lu, David L Paterson
Pageof 58